Watch FOX 17 This Morning LIVE!

Watch FOX 17 This Morning LIVE!


    01/27/15 06:48:20 AM

    We have the newest updates on school closings and winter weather possibilities to the east of Nashville. TUNE IN or STREAM:  click here for more

WZTV - Search Results

The following is an archived video story. The text content of that video story is available below for reference. The original video has been deleted and is no longer available.

Drug Company Will Provide 7-Year-Old With Cancer Drug

Stream WZTV Fox 17 Newscasts LIVE starting with Fox 17 This Morning at 5am and News at 9pm.

FOX News-- After first refusing to provide a drug which could save the life of 7-year-old Josh Hardy, the outcry on social media, phone calls and emails have worked. Josh, who suffers from a rare form of kidney cancer suffers from an adenovirus which is attacking his body. He has been given a drug which could save his life intravenously, but it's the oral form of the medication which could make the difference. 

TUNE IN or STREAM FOX 17 THIS MORNING NOW for the latest on Josh Hardy's story! CLICK HERE

Chimerix, the drug company which develops the drug called Brincidofovir, has given emergency access to the drug to hundreds of patients in the past but stopped the practice because they couldn't afford it. The antiviral drug has not yet been approved by the FDA, so access needs to be given by the company if a patient wants to use the medication. 

Josh Hardy's mom started the grassroots campaign to get her son access to the drug in an effort to save her son's life. I want to be by his bedside, holding his hand, telling him, Its going to be okay, but because of this unwillingness to release this drug, I have to leave him and come talk to you and it infuriates me.

Despite denying the drug at first, Chimerix had a change of heart after Social Media spread the story like wildfire and people took action. CEO Kenneth Moch said his company has received hundreds of phone calls and emails in support of Josh. A Twitter campaign utilizing the hashtag #savejosh has also been launched to support Joshs cause.

Now, Josh will get the treatment he needs at St. Jude's Children's Research Center in Memphis. Chimerix has worked out a deal with the FDA to provide a clinical trial of Brincidofovir and Josh will be the first recipient. 

Follow us on Twitter @wztv_fox17 and LIKE us on Facebook for updates.